Guide · Updated August 2026

Does TRICARE Cover GLP-1 Weight Loss Drugs in 2026?

TRICARE does cover Wegovy, Zepbound, and Saxenda for weight loss, but only for beneficiaries on TRICARE Prime or TRICARE Select, only with an approved prior authorization, and the coverage itself does not mean a low copay. TRICARE's pharmacy contractor states plainly that beneficiaries pay 100% of the cost for weight-loss GLP-1 prescriptions even after prior authorization is approved. TRICARE For Life, direct-care-only, and NATO/Partnership-for-Peace beneficiaries lost weight-loss drug coverage entirely as of August 31, 2025.

That is a confusing setup, and it trips people up because “covered with prior authorization” sounds like it should mean a normal copay. For GLP-1s used for weight loss, it does not.

Here is how the coverage actually breaks down by plan, what the prior authorization process requires, and what changes if the prescription is for type 2 diabetes instead of weight loss.

TRICARE GLP-1 Coverage at a Glance

Coverage rules current as of August 2026. TRICARE’s formulary and prior authorization criteria are reviewed quarterly, so confirm your specific plan’s current status through the TRICARE Formulary Search Tool or Express Scripts before you count on any of this.

Which TRICARE Plans Cover GLP-1s for Weight Loss

TRICARE covers Wegovy, Zepbound, and Saxenda for weight management under prior authorization, but only for beneficiaries enrolled in TRICARE Prime or TRICARE Select. If you are on one of those two plans and your prescriber gets a prior authorization approved, the drug is technically on your formulary.

That coverage does not extend to every TRICARE beneficiary. As of August 31, 2025, TRICARE removed weight-loss drug coverage for beneficiaries who are direct-care-only (meaning they only use military treatment facilities, with no Prime or Select enrollment), those covered under the NATO/Partnership-for-Peace program, and TRICARE For Life beneficiaries, who are Medicare-eligible retirees. If you fall into any of those groups, there is currently no coverage path for a weight-loss GLP-1 prescription through TRICARE, regardless of prior authorization.

This is a meaningful gap for military retirees. TRICARE For Life is the plan most retirees over 65 rely on, and it is explicitly excluded.

One more thing worth knowing: Novo Nordisk has announced it is discontinuing Saxenda, with last shipments to wholesalers expected in early 2027. It remains available in the US as of August 2026, but if your prescriber is starting you on a weight-loss GLP-1 now, ask whether Wegovy makes more sense as the longer-term option.

The Catch: Coverage Does Not Mean a Normal Copay

This is the part that catches people off guard. TRICARE’s pharmacy benefits manager, Express Scripts, states in its own FAQ that beneficiaries pay 100% of the cost for weight-loss drugs even with an approved prior authorization. The standard TRICARE pharmacy copays that apply to most brand-name drugs (roughly $48 for a 30-day retail fill or $44 for a 90-day home delivery fill under 2026 rates) do not apply here. Weight-loss GLP-1s are carved out with their own cost-sharing rule, and that rule is full price.

In practice, that means getting a prior authorization approved for Wegovy or Zepbound on TRICARE Prime or Select confirms the prescription is allowed on your formulary. It does not make the drug affordable the way a normal covered prescription would. You are still paying list price, which runs roughly $1,000 to $1,350 a month for the brand-name pens as of mid-2026.

Getting the Prior Authorization Approved

If you are on Prime or Select and want to pursue coverage anyway (the PA still matters if your plan’s rules change, or if you want the prescription documented as medically necessary), the prior authorization has real requirements behind it. Based on TRICARE’s published PA criteria, expect your prescriber to need to document:

• BMI thresholds. A BMI of 30 or higher qualifies on its own. A BMI of 27 to 29.9 requires at least one weight-related condition, such as hypertension or sleep apnea, documented alongside it.
• A documented history of diet and exercise attempts. TRICARE’s criteria call for at least 6 months of supervised, unsuccessful weight management through diet, exercise, or behavioral counseling before a GLP-1 prescription is approved.
• Step therapy in some cases. Some PA reviews require documentation that lower-cost options, such as phentermine or metformin, were tried first and did not work.
• Renewal. An approved PA is not permanent. Expect it to run roughly 12 months, with renewal tied to showing continued weight loss, generally cited around 5% from your starting weight for adults.

One more wrinkle: if you had a weight-loss PA approved before August 2025, it is worth confirming it is still valid. TRICARE’s August 31, 2025 policy change reset the rules for who can even use the weight-loss benefit, and older approvals for beneficiaries outside Prime and Select are no longer honored.

GLP-1s for Type 2 Diabetes Work Differently

Everything above applies to GLP-1s prescribed for weight loss. If your prescription is for type 2 diabetes, TRICARE treats it like most other maintenance medications. Ozempic, Mounjaro, and Trulicity are covered under TRICARE’s standard pharmacy benefit for diabetes management, subject to a prior authorization and the normal formulary tier copay rather than the 100%-cost weight-loss rule.

The distinction that matters here is the diagnosis code, not the drug. Ozempic and Mounjaro are the same molecules used in Wegovy and Zepbound at different doses, but a diabetes diagnosis unlocks standard coverage while a weight-loss-only diagnosis runs into the rules above. Prescribing Ozempic or Mounjaro off-label for weight loss without a diabetes diagnosis does not get around this. TRICARE reviews the diagnosis tied to the claim.

What to Do If TRICARE Won’t Cover You

Check the formulary before you assume anything. TRICARE’s formulary and prior authorization rules are reviewed quarterly. What was true when a friend went through this six months ago may not be true now. The TRICARE Formulary Search Tool and your regional Express Scripts account are the two places to check before making a decision.

If you’re on Prime or Select, ask your prescriber to submit the PA anyway. Even with the 100%-cost rule, an approved PA at least confirms the drug is on formulary and gives you a documented medical necessity record, which can matter if you later switch plans or if TRICARE revises the cost-sharing rule.

If you’re excluded (TRICARE For Life, direct care only, NATO/PfP), your options are cash pay. That means either the manufacturer’s direct cash-pay programs (Zepbound Direct runs $399 to $549/month for vials as of August 2026) or a licensed compounding provider, which is typically cheaper but is not FDA-approved and is not a generic version of the brand drug. Our copay card and patient assistance guide covers manufacturer savings programs, though note that manufacturer copay cards generally cannot be combined with government insurance like TRICARE.

If cost is the real obstacle regardless of TRICARE, compare the cash-pay market directly. Our cheapest GLP-1 online guide ranks verified provider pricing, including compounded options that run well below TRICARE’s 100%-cost list price.

Bottom Line

TRICARE Prime and Select beneficiaries can get Wegovy, Zepbound, or Saxenda approved through prior authorization for weight loss, but “approved” does not mean “affordable.” The pharmacy contractor’s own rule is that you pay the full cost regardless. TRICARE For Life, direct-care-only, and NATO/PfP beneficiaries have no weight-loss GLP-1 coverage at all as of August 2025. If your prescription is for type 2 diabetes, standard coverage and copays apply instead. Confirm your specific situation through TRICARE’s formulary tool or Express Scripts before assuming either way, since these rules are reviewed quarterly and have already changed once in the past year.

FAQ

Does TRICARE cover Wegovy for weight loss?

Yes, for beneficiaries on TRICARE Prime or TRICARE Select, with an approved prior authorization documenting BMI and a supervised weight-loss attempt. Coverage does not extend to TRICARE For Life, direct-care-only, or NATO/Partnership-for-Peace beneficiaries, and even approved prescriptions are billed at 100% of the drug’s cost rather than a standard copay.

Does TRICARE cover Zepbound?

The same rules apply as Wegovy. Zepbound is covered with prior authorization on TRICARE Prime and Select, but you pay the full cost even when the PA is approved, according to TRICARE’s pharmacy contractor.

Why did TRICARE stop covering weight-loss drugs for some beneficiaries?

TRICARE narrowed weight-loss drug coverage effective August 31, 2025, removing it for TRICARE For Life, direct-care-only, and NATO/Partnership-for-Peace beneficiaries. TRICARE has not published a detailed public rationale for the specific change beyond the policy update itself, so treat any explanation you read elsewhere as speculation unless it cites TRICARE directly.

Does TRICARE cover Ozempic or Mounjaro?

Yes, when prescribed for type 2 diabetes, under TRICARE’s standard pharmacy benefit and normal formulary copay. If either is prescribed off-label for weight loss without a diabetes diagnosis, it falls under the weight-loss rules above instead, meaning prior authorization and full cost even if approved.

What if I’m a military retiree on TRICARE For Life?

As of August 31, 2025, TRICARE For Life does not cover GLP-1 medications for weight loss. Your options are typically your Medicare Part D plan (if it covers GLP-1s for weight management, which varies), a manufacturer cash-pay program, or a licensed compounding provider. Our Medicare GLP-1 coverage guide covers what Medicare itself allows.

This guide describes TRICARE's published policy as of August 2026 and is not a guarantee of coverage for any individual beneficiary. TRICARE's formulary and prior authorization rules change and are reviewed quarterly. Confirm your specific coverage directly with TRICARE, Express Scripts, or your regional contractor before making treatment decisions. Compounded medications referenced here are not FDA-approved and are not generic versions of brand-name drugs. Full details in our disclaimer.

Related

Guides:

• GLP-1 Medicare Coverage in 2026
• How to Get Insurance to Cover GLP-1 Medications
• Cheapest Way to Get GLP-1 Online
• GLP-1 Copay Cards and Patient Assistance

Tools:

• Insurance Coverage Checker
• GLP-1 Cost Estimator

Compare: All Providers